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PreviewsSir William Osler noted that it is “much 
more important to know what sort of 
a patient has a disease than what sort 
of a disease a patient has.” Osler’s 
insight captures the remarkable influ-
ence of environmental circumstances 
on disease burden. Clinical observation 
is essential, but it is the identification 
of the biological pathways that medi-
ate disease that sets science on higher 
ground. On this terrain, we find the 
article in this issue by Cao et al. (2010), 
who describe the mechanisms by which 
more engaging physical and social envi-
ronments might influence tumor prolif-
eration and progression.
Studies of environmental enrichment 
date back several decades to Donald 
Hebb, who noted that rats living within 
more complex environments (his home) 
were less anxious, more curious, and 
quicker to resolve mazes than were 
animals left in the lab. The observation 
launched research on the influence of 
complex physical and social environ-
ments, the conditions that comprise 
“enrichment,” on biological function and 
health (Nithianantharajah and Hannan, 
2006). In their new work, Cao and col-
leagues use several mouse models of 
cancer including colon cancer and mela-
noma to show that environmental enrich-
ment delays tumor growth and increases 
survival. The authors show that putting 
mice in a more complex living environ-
ment increases the expression of the gene 
encoding brain-derived neurotrophic 
factor (BDNF) in the hypothalamus of the 
mouse brain (Figure 1). They then dem-
onstrate that BDNF decreases plasma 
levels of the adipokine leptin through 
increased sympathetic nervous system 
activity and activation of β-adrenergic 
receptors expressed by adipocytes in 
white adipose tissue. The authors used 
in vivo and in vitro approaches to directly 
link the changes in leptin levels to tumor 
growth (the importance of other potential 
mediators such as adiponectin, also pro-
duced by white adipose tissue, remains 
to be clarified).
The centerpiece of this work is the 
focus on the importance of hypothalamic 
BDNF. Viral-mediated increases in hypo-
thalamic BDNF expression mimicked the 
effects of environmental enrichment on 
plasma leptin levels and tumor growth, 
whereas knockdown of BDNF using RNA 
interference eliminated the effects of envi-
ronmental enrichment. The authors con-
clude that life in more complex physical 
and social surroundings boosts hypotha-
lamic BDNF, which increases activation of 
white adipose tissue by the sympathetic 
nervous system and decreases leptin 
secretion, thus decreasing tumor growth 
and progression.
These findings complement those 
examining the influence of social circum-
stances on health, including the develop-
ment of cancer. Social support strongly 
predicts mental well being and is linked 
to improved health outcomes among 
cancer patients (Glaser and Kiecolt-
Glaser, 2005). The Cao et al. study sug-
gests mechanisms by which social fac-
tors might influence tumor growth. The 
influence of social networks is apparent 
in prospective, epidemiological studies, 
which reveal that human social isolation 
predicts the risk for mortality (Berkman 
and Syme, 1979). Similarly, socially iso-
lated rats show significantly increased 
mammary tumor burden (it is the rat’s 
misfortune to spontaneously develop 
mammary tumors) (Hermes et al., 2009). 
Social isolation of the naturally gregari-
ous rat is considered “stressful” and 
reliably increases signals, such as adre-
nal glucocorticoids and noradrenaline, 
that mediate stress responses via the 
sympathetic nervous system. Chronic 
and uncontrollable stress increases 
adrenal glucocorticoid secretion and 
tumor progression (Anisman and Sklar, 
1979). Glucocorticoids and noradrena-
line influence multiple aspects of tumor 
growth including apoptosis, angiogen-
esis (blood vessel formation), invasion, 
and immunological escape as well as 
the metastatic cascade and are thus 
considered potential candidates linking 
stress to cancer (Antoni et al., 2006). The 
evidence has led some to call for the use 
of β-adrenergic receptor blockers as a 
therapeutic intervention in the treatment 
of cancer (Melamed et al., 2005).
It all seems so simple: social isolation 
in small stifling environments enhances 
stress mediators and advances tumor 
progression, whereas enrichment 
affording physical and social complexity 
restrains tumor growth. It all fits nicely 
until we realize that the same villains that 
mediate the tumorigenic effects of stress 
(i.e., glucocorticoids and noradrenaline) 
also form the link between enrichment 
and resistance to developing cancer. Cao 
et al. report, as do others, that enrich-
ment, like physical exercise, increases 
circulating levels of glucocorticoids and 
noradrenaline. Importantly, administra-
tion of the same β-blockers eliminates 
the effects of enrichment. Different tar-
get tissues perhaps? It would seem not. 
In both “stress” and “enrichment” mod-
els, white adipose tissue appears to be a 
critical target for noradrenaline. We have 
a problem!
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Enriched environments are known to boost physical and mental health in rodents and humans. 
Now, Cao et al. (2010) report that environmental enrichment also suppresses tumor growth in mice 
by stimulating the hypothalamus to produce brain-derived neurotrophic factor that acts on the 
sympathetic nervous system to reduce leptin production in white fat tissue.Cell 142, July 9, 2010 ©2010 Elsevier Inc. 15
The resolution may, in 
part, lie in the misunder-
standing of the effects of 
glucocorticoids and nora-
drenaline. Both hormones 
are reliably increased by 
stress, so much so that 
they are considered sig-
natures of stressful condi-
tions. But these hormones 
are metabolic regulators, 
catabolizing energy stores 
to meet immediate meta-
bolic demands. Environ-
mental enrichment and 
physical exertion demand 
energy, and the call is met 
by increased levels of glu-
cocorticoids and noradren-
aline. Cao and coworkers 
rightly point out that Hans 
Selye, an endocrinologist 
who first imported the study 
of stress into experimen-
tal medicine, noted that 
departures from homeosta-
sis could be “eustressful” 
(positive or neutral stress) 
or “distressful” (nega-
tive stress) and that health 
effects would vary accord-
ingly. Our ability to under-
stand the nature of path-
ways linking environmental 
circumstances to health is 
poorly served by research 
that fails to note this dis-
tinction. Indeed, perhaps it 
might be better to abandon 
the term “stress” altogether 
in favor of an approach 
that provides a detailed 
description of the relevant 
environmental conditions 
(ideally ones that map onto 
the relevant human disease), the health 
outcomes, and the mechanisms that lie 
in between. And lest one rush to canon-
ize BDNF, we note that, like the stress 
hormones, BDNF is increased by both 
enrichment and chronic stress.
The ultimate explanation for the appar-
ent stress hormone paradox will involve 
the identification of underlying molecular 
mediators. Glucocorticoids, for exam-
ple, act through a nuclear receptor, the 
glucocorticoid receptor, which is also 
a transcription factor. The direction of 
such transcriptional effects depends 
upon the intracellular signaling context. 
Thus, the c-Jun and c-Fos components 
of the AP-1 transcription factor determine 
whether glucocorticoid receptor acti-
vation has a positive or negative effect 
on transcription (Diamond et al., 1990): 
same hormone, same receptor, opposite 
outcome—sound familiar?
These issues aside, the marriage of 
neuroscience and oncology has impor-
tant implications for cancer treatment. 
Depression is common among cancer 
patients and is associated with 
decreased survival. Among its 
evils, depression is charac-
terized by social withdrawal 
and decreased physical activ-
ity. Such considerations have 
spawned numerous stud-
ies on the potential benefits 
of psychotherapy for cancer 
patients, with some posi-
tive results (Andersen et al., 
2008). Patients that experi-
ence successful psychother-
apy become physically and 
socially more engaged in life 
and hence experience circum-
stances akin to environmental 
enrichment. But what might 
be the mechanism for such 
effects? Cao et al. conclude 
that “hypothalamic BDNF 
signals hormonal events that 
regulate tumor progression.” 
This is a very reasonable con-
clusion but begs the obvi-
ous question: what signals 
to hypothalamic BDNF? This 
question lies at the heart of the 
distinction between eustress 
and distress. The signal is 
certainly extrahypothalamic. 
Brain regions that respond 
to environmental enrichment 
include the medial prefron-
tal cortex and hippocampus, 
each of which regulates hypo-
thalamic function. Serotonin 
(5-HT) is a major regulator of 
neural BDNF expression, and 
5-HT function is altered in 
depression. The medial pre-
frontal cortex, which regulates 
both neural 5-HT and sympa-
thetic systems, and which 
responds to environmental 
enrichment in rodents and psycho-
therapy in humans, is a brain region to 
consider in distinguishing the influence 
of eustressful and distressful events on 
health.
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figure 1. A Richer Life Stops Tumors in Their Tracks
The medial prefrontal cortex of the rodent brain may mediate the evaluation 
of environmental stimuli as eustressful (positive stress) or distressful (negative 
stress). This region is connected through multiple pathways to the hypothala-
mus, which regulates the activity of both the sympathetic nervous system 
(SNS) and the hypothalamic-pituitary-adrenal (HPA) axis. These systems pro-
duce the so-called stress hormones—glucocorticoids and noradrenaline—in 
response to environmental events. Both distressful events (social isolation, 
unpleasant environments) linked to impaired health and eustressful events 
(environmental enrichment, moderate physical exercise, caloric restriction 
with adequate nutrition) associated with improved health can similarly in-
crease SNS and HPA activity with effects on multiple tissues including white 
adipose tissue. An enriched environment stimulates the hypothalamus to pro-
duce brain-derived neurotrophic factor (BDNF), which stimulates the SNS and 
HPA to boost production of glucocorticoids and noradrenaline. Noradrenaline 
activates white adipose tissue via β-adrenergic receptors to produce less lep-
tin but more adiponectin resulting in reduced growth of tumors (Cao et al., 
2010). Remarkably, however, glucocorticoids and noradrenaline also medi-
ate distressful events resulting in increased leptin production, decreased adi-
ponectin, and the promotion of tumor growth. One explanation for this stress 
hormone paradox is that differential processing of environmental information 
at the level of the medial prefrontal cortex (or related structures) affects the in-
tracellular context at peripheral target tissues thus altering how cells respond 
to stress hormones.16 Cell 142, July 9, 2010 ©2010 Elsevier Inc.
Antoni, M.H., Lutgendorf, S.K., Cole, S.W., Dhab-
har, F.S., Sephton, S.E., McDonald, P.G., Stefanek, 
M., and Sood, A.K. (2006). Nat. Rev. Cancer 6, 
240–248.
Berkman, L.F., and Syme, S.L. (1979). Am. J. Epi-
demiol. 109, 186–204.
Cao, L., Liu, X., Lin, E.-J.D., Wang, C., Choi, E.Y., 
Riban, V., Lin, B., and During, M.J. (2010). Cell, this 
issue.
Diamond, M.I., Miner, J.N., Yoshinaga, S.K., and 
Yamamoto, K.R. (1990). Science 249, 1266–1272.
Glaser, R., and Kiecolt-Glaser, J.K. (2005). Nat. 
Rev. Immunol. 5, 243–251.
Hermes, G.L., Delgado, B., Tretiakova, M., Cavi-
gellia, S.A., Krausza, T., Conzena, S.D., and Mc-
Clintock, M.K. (2009). Proc. Natl. Acad. Sci. USA 
106, 22393–22398.
Melamed, R., Rosenne, E., Shakhar, K., Schwartz, 
Y., Abudarham, N., and Ben-Eliyahu, S. (2005). 
Brain Behav. Immun. 19, 114–126.
Nithianantharajah, J., and Hannan, A.J. (2006). 
Nat. Rev. Neurosci. 7, 697–709.Cell 142, July 9, 2010 ©2010 Elsevier Inc. 17
The tumor suppressor p53 is one of 
the key sentinels in the cell for moni-
toring the integrity of genomic DNA. 
When deleterious mutations occur, 
p53 launches a DNA repair pathway 
and arrests the cell cycle to protect 
daughter cells from inheriting poten-
tially mutagenic DNA (Vousden and 
Prives, 2009). Exquisitely sensitive to 
DNA damage, p53 can respond to even 
one or two breaks in nuclear DNA, but 
it apparently ignores harmless breaks 
that naturally form as DNA is opened 
during the replication phase of the cell 
cycle. Thus, a central question has 
been how p53 maintains its high sen-
sitivity to mutagenic damage while 
simultaneously overlooking benign 
breaks during normal cell division. In 
this issue of Cell, Loewer et al. (2010) 
use an elegant single-cell microscopy 
approach to address this fundamen-
tal question. They find that the activity 
of p53 is surprisingly uncoupled from 
its cellular concentration; instead, its 
activity depends on the interplay of 
inhibitory and activating posttransla-
tional modifications.
The classical model for activation of 
p53 is based primarily on experiments 
with large cell populations. These stud-
ies concluded that the levels of p53 
protein in the cell are kept low under 
normal cell-cycle conditions. DNA dam-
age triggers an initial boost in p53 con-
centration in the cell by activating the 
p53 promoter and stabilizing existing 
p53 protein (Kruse and Gu, 2009). If the 
DNA damage persists, p53 then can 
kick off a cell-cycle arrest response in 
part by stimulating gene expression of 
specific targets, including p21. Eventu-
ally, the activity of p53 is attenuated as 
it switches on another key target gene, 
mdm2. The Mdm2 protein represses 
transcriptional activation of p53 while 
simultaneously lowering p53 protein lev-
els through ubiquitin-mediated degrada-
tion (Vousden and Prives, 2009; Kruse 
and Gu, 2009).
In their new study, Loewer et al. (2010) 
now uncover a new twist in the mecha-
nism of p53 activation. By examining 
individual cells with time-lapse micros-
copy, they find that the levels of p53 
protein actually pulse up and down dur-
ing the normal cell cycle. Furthermore, 
the bursts in p53 concentration require 
kinases, such as the ataxia telangiecta-
sia mutated (ATM) kinase, which phos-
phorylates and stabilizes p53 (Vousden 
and Prives, 2009; Kruse and Gu 2009). 
These oscillations in p53 during nor-
mal growth were not detected by ear-
lier studies because they average out 
over a population of cells. Interestingly, 
Loewer et al. find that these “normal” 
pulses, which are probably triggered by 
transient DNA damage during DNA rep-
lication, do not lead to activation of p21 
or cell-cycle arrest. In contrast, bursts 
of p53 triggered by extrinsic mutagens, 
such as radiation and drugs, do activate 
p21 and halt cell division. Remarkably, 
the intensity and duration of these p53 
pulses were similar under both condi-
tions. How then does p53 differentiate 
between benign breaks in DNA and 
potentially dangerous ones?
Loewer and colleagues find that the 
critical signal controlling the activity of 
p53 is an intricate balance of alterna-
tive posttranslational modifications of 
p53. Recent studies have found that, 
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How do regulatory switches achieve high sensitivity within the noisy cellular milieu? Loewer et al. 
(2010) now use single-cell microscopy to demonstrate that alternative posttranslational modifica-
tions allow the tumor suppressor p53 to differentiate between benign breaks in DNA during the cell 
cycle and deleterious damage caused by mutagens.
